Federal Register / Vol. 89, No. 197 / Thursday, October 10, 2024 / Notices 82255 

part 1, 43 CFR part 45, and 50 CFR part 

221, to implement section 241 of the 

Energy Policy Act of 2005 (EP Act), 

Public Law 109–58, enacted on August 

8, 2005. Section 241 of the EP Act added 

a new section 33 to the Federal Power 

Act (FPA), 16 U.S.C. 823d, that allowed 

the license applicant or any other party 

to the license proceeding to propose an 

alternative to a condition or prescription 

that one or more of the Departments 

develop for inclusion in a hydropower 

license issued by the Federal Energy 

Regulatory Commission (FERC) under 

the FPA. This provision required that 

the Department of Agriculture, the 

Department of the Interior, and the 

Department of Commerce collect the 

information covered by 1094–0001. 

Under FPA section 33, the Secretary 

of the Department involved must accept 

the proposed alternative if the Secretary 

determines, based on substantial 

evidence provided by a party to the 

license proceeding or otherwise 

available to the Secretary, (a) that the 

alternative condition provides for the 

adequate protection and utilization of 

the reservation, or that the alternative 

prescription will be no less protective 

than the fishway initially proposed by 

the Secretary, and (b) that the 

alternative will either cost significantly 

less to implement or result in improved 

operation of the project works for 

electricity production. 

In order to make this determination, 

the regulations require that all of the 

following information be collected: (1) a 

description of the alternative, in an 

equivalent level of detail to the 

Department’s preliminary condition or 

prescription; (2) an explanation of how 

the alternative: (i) if a condition, will 

provide for the adequate protection and 

utilization of the reservation; or (ii) if a 

prescription, will be no less protective 

than the fishway prescribed by the 

bureau; (3) an explanation of how the 

alternative, as compared to the 

preliminary condition or prescription, 

will: (i) cost significantly less to 

implement; or (ii) result in improved 

operation of the project works for 

electricity production; (4) an 

explanation of how the alternative or 

revised alternative will affect: (i) energy 

supply, distribution, cost, and use; (ii) 

flood control; (iii) navigation; (iv) water 

supply; (v) air quality; and (vi) other 

aspects of environmental quality; and 

(5) specific citations to any scientific 

studies, literature, and other 

documented information relied on to 

support the proposal. 

This notice of proposed renewal of an 

existing information collection is being 

published by the Office of 

Environmental Policy and Compliance, 

Department of the Interior, on behalf of 

all three Departments, and the data 

provided below covers anticipated 

responses (alternative conditions/ 

prescriptions and associated 

information) for all three Departments. 

Title of Collection: 7 CFR part 1; 43 

CFR part 45; 50 CFR part 221; The 

Alternatives Process in Hydropower 

Licensing. 

OMB Control Number: 1094–0001. 

Form Number: None. 

Type of Review: Extension of a 

currently approved collection. 

Respondents/Affected Public: 

Business or for-profit entities. 

Total Estimated Number of Annual 

Respondents: 5. 

Total Estimated Number of Annual 

Responses: 5. 

Estimated Completion Time per 

Response: 500 hours. 

Total Estimated Number of Annual 

Burden Hours: 2,500 hours. 

Respondent’s Obligation: Voluntary. 

Frequency of Collection: Once per 

alternative proposed. 

Total Estimated Annual Nonhour 

Burden Cost: None. 

An agency may not conduct or 

sponsor and a person is not required to 

respond to a collection of information 

unless it displays a currently valid OMB 

control number. 

The authority for this action is the 

Paperwork Reduction Act of 1995 (44 

U.S.C. 3501 et seq). 

Stephen G. Tryon, 

Director, Office of Environmental Policy and 

Compliance. 

[FR Doc. 2024–23481 Filed 10–9–24; 8:45 am] 

BILLING CODE 4334–63–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1412] 

Certain NAND Memory Devices and 

Electronic Devices Containing Same; 

Notice of the Commission’s 

Determination Not To Review an Initial 

Determination Terminating the 

Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has determined not to 

review the presiding administrative law 

judge’s (‘‘ALJ’’) initial determination 

(‘‘ID’’) (Order No. 7) terminating the 

investigation based on a settlement 

agreement and withdrawal of the 

complaint. 

FOR FURTHER INFORMATION CONTACT: 

Edward S. Jou, Esq., Office of the 

General Counsel, U.S. International 

Trade Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–3316. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted this investigation 

on August 13, 2024, based on a 

complaint filed by MimirIP LLC of 

Dallas, Texas (‘‘Mimir’’). 89 FR 65931– 

32 (Aug. 13, 2024). The complaint, as 

supplemented, alleges violations of 

section 337 of the Tariff Act of 1930, as 

amended, 19 U.S.C. 1337, based upon 

the importation into the United States, 

the sale for importation, and the sale 

within the United States after 

importation of certain NAND memory 

devices and electronic devices 

containing same by reason of 

infringement of certain claims of U.S. 

Patent Nos. 8,637,919; 9,245,962; and 

10,896,918. The notice of investigation 

named as respondents: Micron 

Technology, Inc. (‘‘Micron’’) of Boise, 

Idaho; Acer Inc. of New Taipei City, 

Taiwan; Acer America Corp. of San Jose, 

California; HP, Inc. of Palo Alto, 

California; Kingston Technology 

Company, Inc. of Fountain Valley, 

California; Lenovo Group Limited of 

Hong Kong, China; and Lenovo (United 

States) Inc. of Morrisville, North 

Carolina (collectively, ‘‘Respondents’’). 

The Office of Unfair Import 

Investigations (‘‘OUII’’) is also a party in 

this investigation. 

On August 28, 2024, Mimir and 

Respondents filed a joint motion to 

terminate the investigation based on a 

settlement between Mimir and Micron 

that resolves all issues as to all 

Respondents in this investigation. On 

September 5, 2024, OUII filed a 

response in support of the motion. On 

September 6, 2024, the ALJ issued Order 

No. 6 requesting additional clarification 

regarding the motion. On September 10, 

2024, Mimir and Micron jointly filed a 

supplement to the motion stating that 

Mimir requests termination of the 

investigation based on withdrawal of 


lotter on DSK11XQN23PROD with NOTICES1
82256 Federal Register / Vol. 89, No. 197 / Thursday, October 10, 2024 / Notices 

the complaint with respect to the 

respondents other than Micron. 

On September 12, 2024, the ALJ 

issued the subject ID granting the joint 

motion to terminate the investigation. 

The ALJ found that the motion 

complied with the requirements of 

Commission Rule 210.21(b)(1) (19 CFR 

210.21(b)(1)) with respect to the 

termination of Micron based on a 

settlement agreement, and the motion 

complied with the requirements of 

Commission Rule 210.21(a)(1) (19 CFR 

210.21(a)(1)) with respect to the 

termination of the remaining 

respondents by withdrawal of the 

complaint. No petitions for review of 

the ID were filed. 

The Commission has determined not 

to review the subject ID. The 

investigation is hereby terminated in its 

entirety. 

The Commission vote for this 

determination took place on October 4, 

2024. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in part 

210 of the Commission’s Rules of 

Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: October 4, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–23403 Filed 10–9–24; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1352] 

Certain Selective Thyroid Hormone 

Receptor-Beta Agonists, Processes for 

Manufacturing or Relating to Same, 

and Products Containing Same; Notice 

of Request for Submissions on the 

Public Interest 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that on 

October 3, 2024, the presiding Chief 

Administrative Law Judge (‘‘Chief ALJ’’) 

issued an Initial Determination on 

Violation of Section 337. The Chief ALJ 

also issued a Recommended 

Determination on remedy and bonding 

should a violation be found in the 

above-captioned investigation. The 

Commission is soliciting submissions 

on public interest issues raised by the 

recommended relief should the 

Commission find a violation. This 

notice is soliciting comments from the 

public and interested government 

agencies only. 

FOR FURTHER INFORMATION CONTACT: 

Houda Morad, Esq., Office of the 

General Counsel, U.S. International 

Trade Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

708–4716. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: Section 

337 of the Tariff Act of 1930 provides 

that, if the Commission finds a 

violation, it shall exclude the articles 

concerned from the United States 

unless, after considering the effect of 

such exclusion upon the public health 

and welfare, competitive conditions in 

the United States economy, the 

production of like or directly 

competitive articles in the United 

States, and United States consumers, it 

finds that such articles should not be 

excluded from entry. (19 U.S.C. 

1337(d)(1)). A similar provision applies 

to cease and desist orders. (19 U.S.C. 

1337(f)(1)). 

The Commission is soliciting 

submissions on public interest issues 

raised by the recommended relief 

should the Commission find a violation, 

specifically: a limited exclusion order 

directed to certain selective thyroid 

hormone receptor-beta agonists, 

processes for manufacturing or relating 

to same, and products containing same, 

imported, sold for importation, and/or 

sold after importation by respondents 

Ascletis Pharma Inc., Ascletis 

Pharmaceuticals Co. Ltd., Ascletis 

Bioscience Co., Ltd., Gannex Pharma 

Co., Ltd., and Jinzi Jason Wu 

(collectively, ‘‘Respondents’’), and cease 

and desist orders against the 

Respondents. Parties are to file public 

interest submissions pursuant to 19 CFR 

210.50(a)(4). 

The Commission is interested in 

further development of the record on 

the public interest in this investigation. 

Accordingly, members of the public and 

interested government agencies are 

invited to file submissions of no more 

than five (5) pages, inclusive of 

attachments, concerning the public 

interest in light of the Chief ALJ’s 

Recommended Determination on 

Remedy and Bonding issued in this 

investigation on October 3, 2024. 

Comments should address whether 

issuance of the recommended remedial 

orders in this investigation, should the 

Commission find a violation, would 

affect the public health and welfare in 

the United States, competitive 

conditions in the United States 

economy, the production of like or 

directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) explain how the articles potentially 

subject to the recommended remedial 

orders are used in the United States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the recommended orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or thirdparty suppliers have the capacity to 

replace the volume of articles 

potentially subject to the recommended 

orders within a commercially 

reasonable time; and 

(v) explain how the recommended 

orders would impact consumers in the 

United States. 

Written submissions must be filed no 

later than by close of business on 

November 4, 2024. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above. The Commission’s paper 

filing requirements in 19 CFR 210.4(f) 

are currently waived. 85 FR 15798 (Mar. 

19, 2020). Submissions should refer to 

the investigation number (‘‘Inv. No. 

337–TA–1352’’) in a prominent place on 

the cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, https://www.usitc.gov/ 

secretary/fed_reg_notices/rules/ 

handbook_on_electronic_filing.pdf). 

Persons with questions regarding filing 

should contact the Secretary (202–205– 

2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment by marking each document 

with a header indicating that the 

document contains confidential 

information. This marking will be 

deemed to satisfy the request procedure 

set forth in Rules 201.6(b) and 

210.5(e)(2) (19 CFR 201.6(b) & 


lotter on DSK11XQN23PROD with NOTICES1